Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "OneSource receives EIR with 'Voluntary Action Indicated' classification from USFDA for its BLD Facility".
Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "OneSource receives EIR with 'Voluntary Action Indicated' classification from USFDA for its BLD Facility".